National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

HMR 1275

 A substance being studied in the treatment of several types of cancer. It stops cells from dividing and may kill cancer cells. It is a type of cyclin-dependent kinase (CDK) inhibitor. Also called alvocidib and flavopiridol.



Previous Definitions:HLA, HLH, HLRCC, HMG-CoA reductase inhibitor, HMGA1
Next Definitions:HNPCC, Hodgkin disease, Hodgkin lymphoma, holmium Ho 166 DOTMP, holy thistle

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov